Cognos and Applix Announce Early Termination of HSR Waiting Period in Connection With Tender Offer

    OTTAWA & WESTBOROUGH, MASS., September 17 /CNW/ - Cognos (NASDAQ:   COGN;
TSX: CSN), the world leader in business intelligence and performance
management solutions, and Applix, Inc. (NASDAQ:   APLX), a publicly held company
based in Westborough, Massachusetts and an industry leader in analytics, today
jointly announced that the Federal Trade Commission (FTC) and the Antitrust
Division of the United States Department of Justice have granted early
termination of the mandatory waiting period under the Hart-Scott-Rodino Act
(HSR) in connection with the cash tender offer by Cognos for all of the
outstanding common stock of Applix, Inc. at a price of $17.87 per share. The
transaction remains subject to the receipt of other regulatory approvals, a
minimum tender of at least a majority of the Applix shares then outstanding on
a fully diluted basis, and other customary closing conditions.

    About Cognos:

    Cognos, the world leader in business intelligence and performance
management solutions, provides world-class enterprise planning and BI software
and services to help companies plan, understand and manage financial and
operational performance. Cognos brings together technology, analytical
applications, best practices, and a broad network of partners to give
customers a complete performance system. The Cognos performance system is an
open and adaptive solution that leverages an organization's ERP, packaged
applications, and database investments. It gives customers the ability to
answer the questions - How are we doing? Why are we on or off track? What
should we do about it? - and enables them to understand and monitor current
performance while planning future business strategies.

    Cognos serves more than 23,000 customers in more than 135 countries, and
its top 100 enterprise customers consistently outperform market indexes.
Cognos performance management solutions and services are also available from
more than 3,000 worldwide partners and resellers. For more information, visit
the Cognos Web site at

    Cognos and the Cognos logo are trademarks or registered trademarks of
Cognos Incorporated in the United States and/or other countries. All other
names are trademarks or registered trademarks of their respective companies.
Note to Editors: Copies of previous Cognos press releases and Corporate and
product information are available on the Cognos Web site at

    About Applix, Inc.

    Applix (NASDAQ:   APLX) empowers agile enterprises by offering the only
complete Business Analytics software solution. The Company is focused
exclusively on providing a single, cohesive Performance Management and
Business Intelligence solution, with strategic planning, forecasting,
consolidations, reporting and analytics across financial, operational, sales
and marketing, and human resources departments. The Applix platform, powered
by the renowned TM1 analytics engine, reaches farther, deploys easier, and
reacts faster than any business analytics solution available today. Applix and
its global network of partners help 3,000 customers worldwide manage their
business performance and respond proactively to the marketplace. Headquartered
in Westborough, MA, Applix maintains offices in North America, Europe and Asia

    Important Information

    This document is for informational purposes only and is not an offer to
buy or the solicitation of an offer to sell any securities. The solicitation
and the offer to buy shares of Applix's common stock will only be made
pursuant to an offer to purchase and related materials that Cognos intends to
file with the securities and exchange commission. Applix will file a
solicitation/recommendation statement with respect to the offer. Once filed,
Applix stockholders should read these materials carefully prior to making any
decisions with respect to the offer because they contain important
information, including the terms and conditions of the offer. Once filed,
Applix stockholders will be able to obtain the offer to purchase, the
solicitation/recommendation statement and related materials with respect to
the offer free of charge at the SEC's website at, from the
information agent named in the tender offer materials, from Applix or from

    Cautionary Statement Regarding Forward-Looking Statements

    Certain statements in this press release regarding the proposed
transaction between Cognos and Applix and any other statements regarding
Cognos' or Applix's future expectations, beliefs, goals or prospects
constitute forward-looking statements made within the meaning of Section 21E
of the Securities Exchange Act of 1934 and Section 138.4(9) of the Ontario
Securities Act. Any statements that are not statements of historical fact
(including statements containing the words "believes," "plans," "anticipates,"
"expects," "estimates" and similar expressions) should also be considered
forward-looking statements. A number of important factors could cause actual
results or events to differ materially from those indicated by such
forward-looking statements, including the parties' ability to consummate the
transaction; the conditions to the completion of the transaction, including a
sufficient number of Applix shares being tendered, may not be satisfied, or
the regulatory approvals required for the transaction may not be obtained on
the terms expected or on the anticipated schedule; and the parties' ability to
meet expectations regarding the timing, completion and accounting and tax
treatments of the merger; the possibility that the parties may be unable to
achieve expected synergies and operating efficiencies in the merger within the
expected time-frames or at all and to successfully integrate Applix's
operations into those of Cognos; such integration may be more difficult,
time-consuming or costly than expected; revenues following the transaction may
be lower than expected; operating costs, customer loss and business disruption
(including, without limitation, difficulties in maintaining relationships with
employees, customers, clients or suppliers) may be greater than expected
following the transaction; the retention of certain key employees of Applix
may be difficult; Cognos and Applix are subject to intense competition and
increased competition is expected in the future; the failure to protect either
party's intellectual property rights may weaken its competitive position;
Cognos is dependent on large transactions; customer decisions are influenced
by general economic conditions; third parties may claim that either party's
products infringe their intellectual property rights; fluctuations in foreign
currencies could result in transaction losses and increased expenses; acts of
war and terrorism may adversely affect either party's business; the volatility
of the international marketplace; and the other factors described in Cognos'
Annual Report on Form 10-K for the fiscal year ended February 28, 2007 and in
its most recent quarterly report filed with the SEC and the Canadian
Securities Administrators, and Applix's Annual Report on Form 10-K for the
fiscal year ended December 31, 2006 and in its most recent quarterly report
filed with the SEC. Cognos and Applix assume no obligation to update the
information in this communication, except as otherwise required by law.
Readers are cautioned not to place undue reliance on these forward-looking
statements that speak only as of the date hereof.

For further information:

For further information: Cognos Steve Milmore, 781-313-2403 or Lois Paul & Partners, LLC Jessica Sutera,
781-782-5789 or Investor Relations: Cognos John Lawlor,
613-738-3503 or Applix Charlotte Locke, 508-475-2441 or Citigate Cunningham Jena Murphy, 617-374-4216 or Investor Relations: Applix Milt Alpern,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890